Holen Sie sich die Stockscreener-App
4.87
7.27%
0.33
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt LFMD?
Forum
Prognose
Aktiensplit
Lifemd Inc Aktie (LFMD) Neueste Nachrichten
LifeMD Inc. (LFMDP) Q1 2026 Earnings: Preferred Shares Dip Despite Narrower-Than-Expected LossRevenue Guidance Range - dars.gov.et
LFMD Q1 2026 Earnings: EPS Surpasses Estimates Despite Lack of Revenue DisclosureFinal Results - dars.gov.et
B.Riley reiterates LifeMD stock Buy rating on telehealth expansion By Investing.com - Investing.com South Africa
B. Riley Securities Initiates LifeMD(LFMD.US) With Buy Rating, Announces Target Price $10 - Moomoo
B.Riley reiterates LifeMD stock Buy rating on telehealth expansion - Investing.com
LFMD SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Anno - The National Law Review
LFMD INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announc - The National Law Review
Enterprise value to revenue forward of LifeMD, Inc. – NASDAQ:LFMD - TradingView
Price to sales forward of LifeMD, Inc. – NASDAQ:LFMD - TradingView
LIFEMD INC PFD SER A 8.875% To Go Ex-Dividend On July 2nd, 2026 With 0.55469 USD Dividend Per Share - 富途牛牛
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock - Sahm
Best GLP-1 Medical Weight Loss Clinics in 2026 | Good Life Health - marketscreener.com
LifeMD Announces Exclusive Collaboration to Launch Direct-to-Patient Self-Pay Program for XYOSTED® (testosterone enanthate) Injection - Sahm
LifeMD, Inc. And Antares Pharma, Inc. Launch Direct-To-Patient Self-Pay Program For XYOSTED (Testosterone Enanthate) Injection - marketscreener.com
LifeMD Partners with Antares on XYOSTED Telehealth Program - TipRanks
LifeMD partners with Antares Pharma on testosterone program By Investing.com - Investing.com Nigeria
Form 8K LifeMD Inc For: 22 June By Investing.com - Investing.com South Africa
LifeMD partners with Antares Pharma on testosterone program - Investing.com
LifeMD to Launch Exclusive XYOSTED Self-Pay Telehealth Program in July across 37 States - TradingView
LifeMD (Nasdaq: LFMD) inks exclusive telehealth collaboration for XYOSTED self-pay program - Stock Titan
LifeMD and Halozyme Announce Exclusive Telehealth Co-Marketing Agreement for XYOSTED Self-Pay Program Launching in July 2026 - Quiver Quantitative
LifeMD, Halozyme link up to sell testosterone therapy online - Stock Titan
LifeMD Inc (LFMD) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
LifeMD Inc (LFMD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
LifeMD Inc (LFMD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
LifeMD Inc (LFMD) Valuation: PE, PB & Fair Value Analysis - TradingKey
LifeMD Inc (LFMD) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
LifeMD Inc (LFMD) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
LifeMD Inc (LFMD) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
LifeMD Inc (LFMD) Institutional Confidence - TradingKey
LifeMD Inc (LFMD) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
LifeMD, Inc. (LFMD) reports Q1 loss, tops revenue estimates - MSN
Understanding Momentum Shifts in (LFMDP) - Stock Traders Daily
LifeMD: A Growing Healthcare Tech Stock, As Q1 Results Confirm Patient Demand - Seeking Alpha
LifeMD Q1 2026 slides: AI-driven care platform beats estimates - Investing.com
Earnings call transcript: LifeMD Q1 2026 beats EPS and revenue forecasts - Investing.com
LFMDP Q1 2026 Earnings: Narrowing Losses as EPS Surpasses EstimatesEarnings Surprise Score - newsline.com
LFMD Technical Analysis | Trend, Signals & Chart Patterns | LIFEMD INC (NASDAQ:LFMD) - ChartMill
LifeMD Inc. (LFMD) Q1 2026 Earnings: EPS Surprise Beats Estimates, Stock Jumps 7.35%Earnings Revision Report - newsline.com
How The Story Is Evolving For LifeMD (LFMD) With An Unchanged Fair Value View - Yahoo Finance
LifeMD (LFMD) CTO Sripad Umesh submits initial Form 3 filing - Stock Titan
LifeMD (LFMD) CTO receives 75,000-share time-vested stock grant - Stock Titan
LFMD Q1 2026 Earnings: EPS Surprise of 11.66% Exceeds Analyst ExpectationsEarnings Surprise Score - newsline.com
LifeMD Appoints Umesh Sripad as CTO, Bringing Over 20 Years of Tech Experience - geneonline.com
LifeMD Appoints Umesh Sripad as Chief Technology Officer - markets.businessinsider.com
LifeMD appoints Umesh Sripad as chief technology officer By Investing.com - Investing.com Nigeria
LifeMD appoints Umesh Sripad as chief technology officer - Investing.com
Ex-IKEA digital chief to lead AI, cybersecurity at telehealth LifeMD - Stock Titan
LifeMD (LFMD) Sheds Nearly 7% as Stock Approaches Key Support LevelsAI Trade Signals - newsline.com
May 2026's Promising Penny Stocks To Watch - Sahm
LFMD Q1 2026 Earnings: Narrower-than-Expected Loss Highlights Operational ProgressLow Growth Earnings - newsline.com
1.79%
0.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):